SecBot SecBot
SC 13G ·Filed Oct 27, 2026

ENTA

ENANTA PHARMACEUTICALS INC
NEUTRAL
Impact 4/10
Processed4h 24m ago SEC0002052113-26-001073
Passive investor 5%+ stake

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002052113-26-001073
Document: Item_7.txt0002052113-26-001073
Document: 0002052113-26-001073-index-headers.html0002052113-26-001073
Document: 0002052113-26-001073-index.html0002052113-26-001073
Document: 0002052113-26-001073.txt0002052113-26-001073
2 reports for ENTA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ENTA — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 4/10
$12.06awaiting T+20—$12.00 (−0.50%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$13.52 $13.24▼ −2.07%▼ −1.01%$12.00 (−11.24%)
Showing 2 of 2

US Market Status

Market Closed — Opens Thu (12h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh ENTA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access